Peripheral Intervention Drug-Eluting Devices Market
Peripheral Intervention Drug-Eluting Devices Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Peripheral Intervention Drug-Eluting Devices Market
Size and Growth
The Peripheral Intervention Drug-Eluting Devices market is poised for substantial growth, driven by rising prevalence of peripheral artery diseases and technological advancements. The market size is projected to reach approximately $XX billion by 2030, reflecting increased demand for minimally invasive treatment options and enhanced patient outcomes in vascular healthcare.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Medtronic plc
◍ Boston Scientific Corporation
◍ Abbott Laboratories
◍ Cardinal Health
◍ B. Braun Melsungen AG
◍ Biosensors International Group Ltd.
◍ C.R. Bard, Inc.
◍ Abbott
◍ The Lubrizol Corporation
◍ Terumo Corporation
The Peripheral Intervention Drug-Eluting Devices Market features key players like Medtronic, Boston Scientific, and Abbott, focusing on innovative designs and therapeutic solutions. These companies enhance market growth through technological advancements and strategic partnerships. Notable sales figures include Medtronic ($30B), Boston Scientific ($12B), and Abbott ($43B) in FY 2022.
Request Sample Report
Market Segmentation
By Application
◍ Plain Old Balloon Angioplasty (POBA)
◍ Percutaneous Transluminal Angioplasty (PTA)
By Product
◍ Drug-Eluting Balloons
◍ Drug-Eluting Stents
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
